当前位置：
X-MOL 学术
›
Antivir. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-8-12 , DOI: 10.3851/imp3188 Roberta Gagliardini 1 , Alessandra Bandera 2 , Mauro Zaccarelli 3 , Gaetana Sterrantino 4 , Alessandra Latini 5 , Alessandro D'Avino 1 , Giuseppe Lapadula 2 , Andrea Antinori 3 , Roberto Cauda 1 , Andrea De Luca 6 , Andrea Gori 2 , Simona Di Giambenedetto 1 , Massimiliano Fabbiani 2
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-8-12 , DOI: 10.3851/imp3188 Roberta Gagliardini 1 , Alessandra Bandera 2 , Mauro Zaccarelli 3 , Gaetana Sterrantino 4 , Alessandra Latini 5 , Alessandro D'Avino 1 , Giuseppe Lapadula 2 , Andrea Antinori 3 , Roberto Cauda 1 , Andrea De Luca 6 , Andrea Gori 2 , Simona Di Giambenedetto 1 , Massimiliano Fabbiani 2
Affiliation
Few data are available about efficacy and durability of simplification from multi-tablet antiretroviral regimens to co-formulated efavirenz (EFV)/emtricitabine (FTC)/tenofovir (TDF) versus rilpivirine (RPV)/FTC/TDF in virologically suppressed HIV-1-infected patients.
中文翻译：
简化为单片治疗方案的3年疗效和持久性：共同配制的依非韦伦/恩曲他滨/替诺福韦和利比韦林/恩曲他滨/替诺福韦的比较。
从多片抗逆转录病毒方案到共同配制的依非韦伦（EFV）/恩曲他滨（FTC）/替诺福韦（TDF）相对于利比韦林（RPV）/ FTC / TDF在病毒学抑制的HIV-1-V中简化的疗效和持久性的可用数据很少感染病人。
更新日期：2020-08-21
中文翻译：
简化为单片治疗方案的3年疗效和持久性：共同配制的依非韦伦/恩曲他滨/替诺福韦和利比韦林/恩曲他滨/替诺福韦的比较。
从多片抗逆转录病毒方案到共同配制的依非韦伦（EFV）/恩曲他滨（FTC）/替诺福韦（TDF）相对于利比韦林（RPV）/ FTC / TDF在病毒学抑制的HIV-1-V中简化的疗效和持久性的可用数据很少感染病人。
京公网安备 11010802027423号